Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Neoplasms × ARQ 197 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Breast Neoplasms 3 Solid Tumors 2 Mesothelioma, Malignant 2 Melanoma 2 Carcinoma 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumor, Pleural 1 Solid Neoplasm 1 Seminoma 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Renal Insufficiency 1 Paraproteinemias 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteolysis 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Malignant Solid Tumour 1 Liver Neoplasms 1 Hypercalcemia 1 Hematologic Neoplasms 1 Fractures, Spontaneous 1

Interventions

Sorafenib 62 Bevacizumab 37 Oxaliplatin 25 Fluorouracil 21 Doxorubicin 19 Gemcitabine 18 durvalumab 17 Nivolumab 17 pembrolizumab 16 Radiosurgery 16 Radiofrequency Ablation 16 Cisplatin 16 lenvatinib 15 Leucovorin 14 Capecitabine 14 atezolizumab 12 Hepatectomy 12 Radiotherapy 11 tremelimumab 10 Irinotecan 10 Cyclophosphamide 10 Carboplatin 9 Blood Specimen Collection 9 Liver Transplantation 8 Ipilimumab 8 Drug Therapy 8 Cryosurgery 8 Chemotherapy, Adjuvant 8 fludarabine 7 Melphalan 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02029157 2017-10-09

JET-HCC

Kyowa Kirin Co., Ltd.

Phase 3 Completed

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡